H
elper T lymphocytes recognize antigenic peptide bound to class II MHC molecules (1) in an interaction involving a panoply of adhesion molecules and coreceptors, the expression of which varies between cells (2) . Analysis of the relative roles of these molecules in different APCs with T cells is therefore very difficult. Complexes of class II MHC molecules and peptide are themselves generated intracellularly after endocytosis and breakdown of foreign Ag (3) . Although indirect methods of peptide occupancy have been used to study this event, they can by nature only infer the way in which complexes form. To circumvent these problems, a number of efforts to generate mAbs specific for given class II MHC/peptide complexes have been made. The first such reagent was isolated by screening anti-I-A b mAbs which revealed that one, Y-Ae, reacts only with a subset of the molecules expressed on some B cells (4) . This reagent has been shown to recognize an endogenously generated peptide derived from the ␣-chain of IE molecules (5) . A similar Ab recognizing an endogenously generated complex of I-A b bound to a fragment of invariant chain has also been generated (6) . Recently, Abs reactive with peptides derived from an exogenous Ag (hen egg lysozyme) bound to I-A b or I-A k have been made using cells carrying a large number of such complexes as immunogens (7, 8) .
In this study, we describe the production of three Abs that recognize a peptide representing the carboxyl-terminal nine amino acids (residues 95-103) of moth cytochrome c (MCC) 3 (IAY-LKQATK) bound to the class II MHC molecule IE k . The recognition of this complex by specific T cells has been the subject of many studies (9 -11) . The Abs described here show very little recognition of empty IE k molecules but react strongly when IE k is loaded with MCC (95-103). All of these mAbs are sensitive to some changes in the sequence of the helices of IE k and of the bound peptide, demonstrating that the epitope of these reagents is very similar to that recognized by TCRs interacting with these complexes. None of these mAbs shows reactivity with free peptide, and although their epitopes overlap they appear to be different. We also find that one of these reagents (G-35) specifically inhibits lymphokine release by two T cells reactive to IE k /MCC (88 -103) but has no effect on a cell recognizing a different IE krestricted peptide.
We have used the highest affinity of these Abs (D-4) to directly investigate by Scatchard analysis the relationship between the number of specific class II MHC/peptide complexes on an APC and the ability of that cell to stimulate T cells. We find that this relationship is very similar for B cells and a transfected fibroblast, suggesting that the number of complexes generated is the key event in T cell activation. We find that 200 -400 complexes per APC are necessary and sufficient to induce a minimal response, whereas maximum stimulation requires Ͼ5000 complexes. Further study shows that although each APC in the population bears sufficient complexes to stimulate, activation of only a small fraction of the T cells present occurs. This indicates that T cell stimulation is stochastic when peptide is limiting, a finding that may help to explain the observations of antagonism and partial agonism in T cell responsiveness.
Materials and Methods

Cells
The T cell line 5C.C7 and hybridomas 2B4 and YO1 have been described previously (10, 12, 13) . The IE k -bearing cell line (CHO-E k ) used to present peptides is a high expressing Chinese hamster ovary (CHO) transfectant (14) . The indicator cell lines for measuring IL-3 and IL-2 concentrations, R6-X and HT-2, respectively, have also been described (15, 16) . All cells were maintained in RPMI 1640 supplemented with 10% FBS, 50 mM ␤-mercaptoethanol, 2 mM L-glutamate, 100 U/ml penicillin, and 100 U/ml streptomycin.
Synthetic peptides
Peptides were synthesized by the Stanford University PAN facility by standard F-moc chemistry. The peptides used had the following amino acid sequences: MCC (88 -103), ANERADLIAYLKQATK; MCC (102S), AN ERADLIAYLKQASK; Hb (64 -76), GKKVITAFNEGLK.
Generation of IE k -peptide complexes
Soluble IE k was obtained as previously described by expression as a phosphoinositide-linked protein in CHO cells (17) . Solubilized purified IE k was bound to appropriate peptide at pH 5 using conditions described previously (17) . Free peptide was removed by ultrafiltration, and the buffer was exchanged to PBS. Approximately 70% of such molecules are occupied with offered peptide as assessed using ELISA (18) .
Generation of mAbs
Mice were primed by i.p. injection using 10 g purified IE k /MCC (88 -103) complex emulsified in CFA (Calbiochem, La Jolla, CA). Mice were boosted by i.p. injection with 10 g complex emulsified in IFA on days 15 and 42. Five weeks after the second boost, the mice were injected i.v. with 10 g complex, and splenocytes were fused to the X63.Ag8.653 myeloma cell line at a ratio of 5. After selection in hypoxanthine-aminopterin-thymine, supernatants from wells containing fused hybridomas were screened for the appropriate reactivities by ELISA as described below. Hybridomas of interest were recloned at least twice to identify stably expressing cells.
Growth and purification of mAbs
mAbs were purified from the supernatants of large scale hybridoma cultures grown in roller bottles or a hollow fiber bioreactor using affinity chromatography with a 1:1 mixture of protein A-and protein G-linked Sepharose (Sigma, St. Louis, MO). The purity of Ab was assessed by 12% SDS-PAGE (19) .
ELISA
Reactivity of supernatants and purified Abs was assessed by coating plates (Immulon IV, Nunc, Naperville, IL) overnight at 4°C with 1 g/ml purified IE k -peptide complexes in PBS. After blocking with PBS containing 2% BSA, Ab at the appropriate concentration, containing competitors where appropriate, was incubated for 1 h at 37°C. After washing, the amount of bound Ab was detected by an incubation with alkaline phosphatase-conjugated goat anti-mouse IgG (Sigma) and color development with Sigma 104 phosphatase substrate. OD was monitored at 405 nm with a microplate reader (Molecular Devices, Palo Alto, CA).
FACS analysis
Adherent cells were released by trypsinization and pulsed with peptide in solution where necessary. Cells were stained with 5 g/ml of the appropriate Ab in PBS containing 10% FBS, and the amount of bound Ab was detected by subsequent incubation with FITC-labeled goat anti-mouse IgG (Sigma). FACS analysis was performed on a FACScan, and cell sorting was performed on a FACSvantage.
Scatchard analysis
FabЈ fragments of D-4 were prepared by papain digestion (20) , purified by size exclusion on a TSK 3000 SW column, and labeled with 125 I (21) to a specific activity of 1 ϫ 10 13 cpm/mol. Preliminary study showed that FabЈ binding to cells reached equilibrium within 1 h. Cells at a concentration of 10 6 /ml were pulsed with different concentrations of MCC (88 -103) for 6 h and were washed three times. Binding assays for Scatchard analysis were performed essentially as described (22) . Briefly, serial dilutions of labeled FabЈ were incubated with cells for 60 min at room temperature in a final volume of 15 l RPMI 1640 with 5% FBS. Cell-bound radioactivity was separated from free FabЈ by centrifugation through an FBS cushion. Nonspecific binding was defined as the cpm bound in the presence of a 500-fold excess of unlabeled FabЈ. The data were analyzed as described (23) .
T cell assays
Assays were performed essentially as described (24) . Briefly, CHO-E k cells that had been prepulsed with different concentrations of peptide were incubated with T cells at the appropriate ratio for 24 h in a volume of 200 ml at 37°C.
Lymphokine activity assays
The supernatants from activation wells were analyzed for IL-3 (5CC7) or IL-2 (hybridomas) levels using indicator cell lines R6-X and HT-2, respectively, as described (17) . Briefly, 5 ϫ 10 3 indicator cells were cultured in six serial dilutions of each supernatant in a volume of 100 l for either 20 (HT-2) or 40 (R6-X) h. Cells were then pulsed with 0.5 Ci [ 3 H]thymidine for 4 h and harvested onto glass microfiber filters. The radioactivity incorporated was determined using a Packard Matrix 96 direct beta counter, and 1 U/ml IL-2 or IL-3 was defined as the concentration of lymphokine at which half-maximal incorporation occurred. The IL-2 and IL-3 activities were calculated by simultaneously fitting the data from a standard and the test supernatants with a four-parameter logistic curve using the ARCUS RADIMM program.
BIAcore analysis
Abs were immobilized on a BIAcore flow cell by amine-targeted chemistry (25) as described previously (26) . Binding of IE k -peptide complexes to the immobilized Ab was performed at room temperature in PBS using a flow rate of 15 l/min and 15-l injections of protein at various concentrations with a BIAcore 2000 (Pharmacia, Piscataway, NJ).
Calcium release
Cells were peptide loaded as in the other assays, and T cells were loaded with the calcium sensitive dye fura-2. The intracellular calcium concentration during the interaction of the cells was followed by fluorescence microscopy as described (27, 28) . Briefly, fura-2-loaded T cells were added onto a patch of confluent CHO cells on the microscope stage. Intracellular calcium in T cells was determined using C-Imaging-1280 System hardware and the Simca Quantitative Fluorescence Analysis Software Package; both from Compix Imaging Systems (Mars, PA). The imaging system was coupled to a Nikon Diaphot 300 inverted microscope which was equipped with the epifluorescence attachment and a 75-W xenon arc lamp (Nikon, Melville, NY). Alternate excitation of fura-2-loaded T cells at 340 and 380 nm was achieved using a Ludl high speed dual filter wheel (Ludl Electronic Products, Hawthorne, NY) controlled by the Simca software. Images were collected with a charge-coupled device camera (Dage-MTI CCD72) in combination with a SuperGenII intensifier (Dage-MTI, Michigan City, IN) to amplify fluorescence. Analysis of intracellular calcium and the generation of figures were achieved with the Simca software package. Per run, 30 -40 cells were picked at random and analyzed. Data of two sets of experiments were pooled.
Results
Production of mAbs specific for IE k -MCC (88 -103)
IE
k heterodimers produced as glycophosphatidylinositol-linked chimeras (piIE k ) are functionally "empty" of endogenous ligand, and Ͼ60% of these molecules can be loaded with a given peptide in vitro (18, 29) . This prompted us to try to generate Abs specific for a complex of IE k and a particular peptide, using the carboxylterminal residues of MCC(95-103) as a model. Either syngeneic (H-2 k ) or allogeneic (H-2 d ) mice were immunized and boosted with piIE k /MCC(88 -103) complexes using a standard protocol. ELISA of serum samples showed that both strains made a polyclonal Ab response that reacted with both the immunogen and with piIE k that was not prebound to any peptide. Approximately 200 hybridomas were recovered from both strains, and supernatants from these were screened by ELISA for reactivity to piIE k either unbound or associated with MCC(88 -103). Twenty-six hybridomas had measurable reproducible reactivity, of which the majority (23) were BALB/c derived. Most of these hybridomas, exemplified by G-23, produce IE k -reactive Abs with peptideindependent specificity as assessed by titration of supernatant activity for IE k Ϯ MCC (Fig. 1A) . Three independently derived clones from the fusion of BALB/c spleen cells (D-4, G-32, and G-35) produced Abs that preferentially recognize IE k associated with MCC as assessed by ELISA (Fig. 1A) .
To examine further the peptide requirement for reactivity of these Abs, we analyzed their binding to a CHO cell line expressing transfected native IE k (CHO-E k ) after a pulse with 20 M MCC(88 -103) peptide. Abs D-4 and G-35 show no staining of these cells above background unless the cells are treated with peptide (Fig. 1B) . In contrast, the G-32 Ab is able to recognize the IE k molecules on these cells even if they had not been treated with peptide, although the signal does increase slightly after pulsing (Fig. 1B) . These results are compared with those of a fourth Ab obtained in this series (G-23), which shows no indication of peptide sensitivity in the ELISA or in the FACS assay (Fig. 1B) .
Sensitivity of Abs to peptide and MHC substitutions
To map the epitopes recognized by these Abs, we examined the effects of substitutions of either the peptide or IE k sequence on reactivity. Fig. 2 shows the sensitivity of recognition to selected monosubstituted analogues of MCC(88 -103) peptide bound to soluble IE k as assessed by ELISA. Separate peptides substituted at residues 97, 99, and 102 were used because these three positions have been shown to interact with certain TCRs (11, 30) . Two analogues at each position were tested. At positions 97 and 102, the original amino acid was replaced with either a positive (lysine) or a negative (glutamate) charge to maximize potential disruption. At position 99 where the original residue was positively charged (lysine), a glutamine or glutamate was introduced. All six substituted peptides bind to IE k as effectively as the wild-type peptide (11) and are capable of stimulating specific T cell responses (31) .
G-23 recognizes IE k bound to all six substituted peptides as effectively as unbound or associated with the unrelated Hb peptide. In contrast, recognition by D-4, G-32, and G-35 is affected by the sequence of the bound peptide but shows different patterns of reactivity. G-35 is the most sensitive, with both substitutions at position 102 and replacement with glutamate (but not glutamine) at position 99 ablating recognition. Reactivity, however, is insensitive to the two analogues substituted at position 97 tested here. In contrast, although alteration of peptide sequence markedly reduced recognition by D-4 and G-32, none of these alterations fully ablates reactivity. Thus, D-4 reactivity is reduced by both changes at position 97 and by one of each of the alterations at positions 99 (E not Q) and 102 (K not E), whereas recognition by G-32 is only significantly reduced by alteration at position 102.
To analyze the effect of MHC sequence on Ab recognition, we used the 13 mutants of IE k described by Ehrich et al. (32) , where each cell line expresses a molecule specifying a single substitution of an amino acid predicted to reside on the ␣ helix. These cell lines were pulsed with wild-type MCC(88 -103) peptide, stained with Ab, and analyzed by cytofluorography. Fig. 3 shows a summary of To further define the epitope recognized by these reagents, we next examined their ability to cross-compete by inhibition ELISA. Each Ab was biotinylated, and the ability of different concentrations of unmodified ("cold") Abs to inhibit recognition of IE k -MCC complexes during coincubation was measured (Fig. 4) . The peptide-independent Ab G-23 inhibits its own reactivity but does not affect recognition by D-4, G-32, or G-35. In contrast, recognition with biotinylated G-35 is inhibited in a dose-dependent manner by G-35 and more effectively by G-32 and D-4. The reactivities of biotinylated G-32 and D-4 were both inhibited in a similar dose-dependent way by unmodified G-32 and D-4 but were only marginally affected by G-35. These results suggest that D-4, G-32, and G-35 have overlapping epitopes on the IE-MCC complex but that G-35 has a lower affinity.
In a similar analysis, we found that recognition by D-4, G-32, and G-35 could be specifically inhibited by IE k complexed with appropriate peptide but was unaffected by incubation with very high concentrations of any free peptide tested (data not shown).
Affinity of Abs
To further examine the specificity of the Abs with regard to peptide occupancy, we directly assessed their affinity for IE k molecules bound to different peptides using surface plasmon resonance. Abs were immobilized on separate sections of a BIAcore (Pharmacia Sensor) chip, and increasing concentrations of IE k preloaded with either MCC(88 -103) or Hb(64 -76) were passed over the surface. fast as 14.4.4S, but their off rates differ considerably: D-4 dissociation is 10-fold slower, whereas G-35 is 10-fold faster. The inability to measure association of D-4 and G-35 with IE k /Hb complexes using this technique indicates that their affinities must be Ͻ100 M, because we can measure such values for interaction of the same IE k -peptide complexes with soluble TCR (26) .
Specific inhibition of T cell responses
To test whether the IE k -MCC(88 -103)-specific Abs generated represented "surrogate" TCRs, we next examined their ability to specifically block T cell recognition (Fig. 6 ). The T cell clone 5C.C7 and the T cell hybridoma 2B4 both recognize MCC(88 -103) restricted by IE k , and their specificities have been extensively studied (11), whereas the hybridoma YO1 recognizes Hb(64 -76) in conjunction with IE k (13) . Although the response of all three T cells is inhibited by Ab G-32, those to MCC are abrogated at 0.1 g/ml, whereas equivalent inhibition of YO1 requires Ͼ10 g/ml Ab. Recognition by all three T cells is also inhibited by the peptide-independent G-23 Ab at concentrations Ͼ1 g/ml. In contrast to these results, although Ab G-35 inhibits the response of both 5C.C7 and 2B4 at Ͼ1 g/ml, it has no effect on the responsiveness of YO1 at concentrations up to 200 g/ml. Surprisingly, the Ab D-4, the epitope of which overlaps that of G-32 and G-35 (Figs. 2  and 3) , and which has the highest affinity (Table I) , is very poor at inhibiting responses by the MCC(88 -103)-specific T cells. Additional experiments showed that the concentration of G-35 necessary to inhibit specific recognition is dependent on the concentration of peptide used to pulse the APCs (data not shown). Additionally, high levels of D4 partially inhibit T cell responses specifically when APCs are pulsed with very low peptide concentrations (data not shown).
Quantitation of stimulatory MHC-peptide numbers
We next decided to use Scatchard analysis with D-4 to directly examine the relationship between number of MHC-peptide complexes on an APC and its ability to stimulate T cells. FabЈ fragments were prepared, and their affinity after iodination for IE k -MCC on peptide pulsed cells was found to be 2-5 nM (data not shown), in general agreement with the value measured using a biosensor. We next determined the number of D-4-reactive sites Table I generated on CHO-E k cells that had been prepulsed with different concentrations of MCC(88 -103). After removal of excess peptide, the ability of these cells to stimulate different T cells at varying T:APC ratios was also established, and the same cells were analyzed by FACS after staining with D-4. Fig. 7A shows the response of the cell line 5C.C7 to these cells using standard assay conditions. This shows that these APCs can cause this T cell to release lymphokine only after being pulsed with Ͼ30 nM peptide. Similar results were observed for the hybridoma 2B4 and for T cells obtained from a mouse transgenic for the TCR expressed by 5C.C7 (34) . Fig. 7A also shows the result of the Scatchard analysis for these cells, and Fig. 7B shows the relationship between number of complexes generated and stimulation capacity. The data presented in Fig. 7C indicates that there are 200 endogenous IE k -peptide complexes on the CHO-E k cells that can interact with D-4, representing 10 Ϫ4 of total IE k molecules expressed. At least a further 200 -400 specific complexes per cell, corresponding to a peptide pulse of 10 -30 nM, are needed for the cells to be active in T cell stimulation, whereas maximum stimulation is attained at ϳ5000 complexes per cell. Fig. 7D shows that the staining intensity of D-4 by FACS mirrors the increase in the number of complexes. In a separate experiment, we also determined the number of complexes generated after pulsing with a partial agonist for this cell line, MCC(102S), and found these to be almost identical (Fig. 7, A  and D) . In addition, we examined the relative ability of a B cell line (CH-27) compared with CHO-E k cells to stimulate the 5C.C7 cell line (Fig. 7C) . Although these cells load peptide more poorly, the relationship between the number of complexes formed and T cell stimulation capacity was almost identical.
. Kinetic rate constants and derived equilibrium constants for the indicated Abs as determined by surface plasmon resonance
To further understand what the limited activation observed in culture represents, we analyzed the responsiveness of 5C.C7 at different ratios of T:APC. As shown in Fig. 8A , restricting the number of T cells present imposes a limit on the maximum IL-3 that can be released, representing maximal activation of each cell. Thus, 820 T cells produce a maximum of 2 U/ml IL-3, indicating that each cell can release 0.0025 U/ml (0.0005 U/cell). In addition, Fig. 8B shows that a fixed number of APCs with different numbers of complexes have only a limited capacity to stimulate. Thus, cells pulsed with the limiting concentration of peptide (30 nM) can elicit only 3 U/ml of IL-3 irrespective of the number of T cells added. This corresponds to a maximal stimulation of 1200 T cells.
One possible explanation for this result is that although the average number of IE k -MCC complexes per cell is 400, there is a skewed distribution such that a small stimulatory population exists that expresses many more. If a single T cell interacts with a single APC, then to account for the observed IL-3 release it would only be necessary for 2.5% of the APCs to have sufficient complexes. To test this hypothesis directly, we used the ability to assess complex number by FACS to remove the top 20% expressing cells after a pulse with 30 nM peptide. As shown in Fig. 8C , this had no effect on T cell stimulation. Additionally, fitting the Scatchard data to a binomial equation, assuming that peptide loading is noncooperative, illustrates that the SD for the number of complexes per cell after a 30 nM pulse would only be Ϯ18 (Dr. Ron Kantor, unpublished observation). This implies that none of the cells in this population would express more than 500 IE k -MCC complexes. Taken together, these findings indicate that all of the cells in the APC population have approximately equivalent stimulatory capacity.
We next examined whether the limited activation observed represented partial activation of all added T cells, or full activation of a limited subset. Previous studies in a different system using a reporter gene suggested that the latter is the case (35) . In our studies, we decided to examine the Ca 2ϩ release after stimulation with cells carrying different numbers of complexes. Accordingly, cells were pulsed with peptide as above and were incubated with T cells. Ca 2ϩ release was assessed by fluorescence microscopy, and the results are shown in Fig. 8D . This indicates that when peptide is limiting, only a small number of T cells are being stimulated, even though the analysis above shows that all of the APCs have equivalent number of complexes. This strongly suggests that there is a stochastic component to T cell activation within this range. The finding that there is a maximum degree of stimulation also indicates that those cells that are not activated by such an encounter become refractory to further stimulation within the time course of the assay.
Discussion
In this report, we use standard hybridoma technology and soluble class II MHC-peptide complexes to generate a set of specific mAbs with reactivities that are sensitive to changes in both the helices of IE k and the sequence of bound peptide. The observed patterns of mutant sensitivity indicate that the epitopes of these mAbs partially overlap with those of TCRs for the same ligand (11, 32) . Similar to the report of Porgador et al. (36) , we find that these reagents show differential sensitivity to bound peptide. Thus, two of the mAbs (D-4 and G-35) show essentially no reactivity with endogenous complexes generated in transfectants or in B cell lines (data not shown), whereas G-32, with a DNA sequence that suggests it is a somatic variant of G-35 (Y. Fukui, unpublished data), seems reactive to many endogenous peptide/IE k complexes. Similar to recognition by TCRs, it appears that relatively small differences in sequence can dramatically affect sensitivity to the peptide bound to an MHC molecule. These Abs in some ways seem more sensitive to changes in peptide than T cells because they fail to react with complexes of IE k bound to the peptide (95-104) derived from pigeon cytochrome c as assessed by ELISA (data not shown). These reagents can be used in many immunochemical assays tested including FACS, Scatchard analysis, ELISA, immunoprecipitation, and immunofluorescence (P.A.R., unpublished observations), but not Western analysis. Use of a biosensor indicates that they have an affinity for IE k bound to a correct peptide which is at least 5 orders of magnitude greater than that for empty or incorrectly occupied molecules.
The similarity between these reagents and TCRs is further suggested by the observation that one of them (G-35) specifically and efficiently inhibits the release of lymphokines by different T cells in response to IE k -MCC. Interestingly, Ab D-4, which has a higher affinity for the IE k -MCC complex (Table I ), was extremely poor at inhibiting lymphokine release by these T cells. This differential blockade of T cell activation in vitro by G-35 and D-4 is mirrored by their relative effectiveness at blocking positive selection of developing thymocytes specific for IE k -MCC in vivo (37) . Although these Abs interact with different kinetics and affinities, it seems unlikely that this is an explanation for preferential inhibition by G-35 because this has the lowest affinity and fastest off rate (Table  I ). The faster on rate for G-35 is unlikely to be exerting an effect because the APCs were preincubated with Ab in our experiments. Although partially overlapping, the epitopes for these Abs are clearly different, and it is possible that this influences efficiency of inhibition. Thus, whereas D-4 is most sensitive to substitutions throughout the MCC peptide sequence (Fig. 2) , it may be unable to block access for TCR engagement, although this seems unlikely because a soluble TCR inhibits interaction of this Ab with IE k -MCC complexes on cells (26) . Alternatively, it is possible that G-35 is more potent because it binds in a such a way that it also hinders additional interactions of IE k . Recognition by G-35 is sensitive to alterations in more of the ␤ helical residues of IE k tested than D-4, suggesting that it may interact more with the MHC molecule itself. The region of IE k to which G-35 appears to bind (␤59-␤64, Fig. 3 ) partially overlaps the site in HLA-DR1 (␤58 -␤69) detected by Ab KL-295, which undergoes a conformational change after association with peptide (38) . Such a peptide-dependent alteration may play an important role in generating arrangements of IE k -MCC complexes that are stimulatory for T cells, perhaps by altering multimerization on the surface of the APC. Supporting such a role is the observation that Ab G-32, which has an epitope similar to that of G-35 but is less sensitive to sequence of bound peptide, is particularly effective at inhibiting responses of T cells (Fig. 6 ). This area may be less occluded in class II MHC molecules than the corresponding region of class I after TCR binding as a result of the more orthogonal mode of interaction (39) .
The generation of these mAbs has allowed us to directly quantitate the relationship between number of antigenic complexes per cell and lymphokine release by T cells. We find that 200 -400 complexes per cell are necessary and sufficient to activate at least a small fraction of coincubated T cells. This is consistent with previous indirect studies that have estimated fractional class II MHC occupancy using either radiolabeled peptide or a functional readout (40 -42) . We find that the same number of limiting complexes is sufficient to stimulate two different T cells maintained in vitro as well as ex vivo T cells. The quantitation of loading of a B cell line (CH27) with MCC peptide assessed using D4 is almost identical with that previously reported by Kimachi et al. (42) using a radioiodinated peptide of related sequence. In contrast to this result, it has been reported that the number of complexes necessary to stimulate class I MHC-restricted T cells can vary greatly (43) . Indeed, one report has suggested that a single complex may be sufficient (44) . Although it is possible that the activation of class I MHC-restricted T cells is much more sensitive than class II MHCrestricted cells, such indirect measurements are susceptible to a number of errors (43) . In particular, the need to use much higher concentrations of cells when binding radiolabeled peptide to achieve quantifiable signal compared with those used in pulsing for T cell lysis may underestimate loading necessary for stimulation because the effective concentration of receptors differs. Analysis similar to that described in this report using the recently described Abs specific for class I MHC-peptide complexes (36, 45) may resolve some of these discrepancies.
Previous quantitative studies have been unable to measure the number of complexes generated on per cell basis. We have therefore used these reagents to investigate what "minimal activation" represents. We find that a population of cells expressing minimal levels of antigenic complexes can only elicit a fractional lymphokine release, irrespective of the number of T cells added. This is not due to a skewed distribution of complexes within the population because removal of the top 20% of APCs with the highest D-4 expression had no effect on stimulation capacity. We also find that at this margin only a fraction of T cells are induced to release their intracellular stores of calcium. The direct implication of these results is that at limiting Ag dose, which is probably the level at which most real T cell responses occur, activation of T cells is stochastic even when the APC has sufficient complexes to activate. A recent report (46) indicated that very small numbers of class II MHC-peptide complexes (1-10), although being unable to elicit lymphokine release, can induce an anergic effect on T cells. This may underpin the findings in this study, because at the margin the decision may be variable. The molecular reasons for this densitydependent effect are unclear but may be related to the rate at which complexes multimerize or otherwise interact to induce the TCR down-regulation that seems to occur (47, 48) . These findings also suggest a possible explanation for the finding that the positive or negative selection of some developing class I MHC-restricted T cells can be mediated by different concentrations of the same peptide (49) .
